AbbVie Inc. against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-09T20:01:20+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month ABBV is +10.2% and MRNA +65.9%; over year to date ABBV is +21.0% and MRNA +663.0%. The ABBV/MRNA price ratio stands at 1.2288, below its 50-day average of 2.2835, and below the 200-day average of 3.9923. A ratio above its own average means ABBV is gaining on MRNA; on this reading the recent edge belongs to MRNA.
| ABBV | MRNA | |
|---|---|---|
| Price | $276.47 | $225.00 |
| 1 day | +1.5% | +14.2%lead |
| 5 days | +5.2% | +18.4%lead |
| 1 month | +10.2% | +65.9%lead |
| 6 months | +30.2% | +338.8%lead |
| Year to date | +21.0% | +663.0%lead |
| 52-week position | 99% of range | 100% of range |
| 52-week range | $190.75–$277.60 | $22.28–$225.00 |
| vs 50-day average | above $258.89 | above $138.26 |
| vs 200-day average | above $232.65 | above $72.63 |
| RSI (14) | 73 | 72 |
| Next earnings | 2026-10-30 | 2026-11-05 |
ABBV trades at $276.47, above its 50-day average of $258.89, and above the 200-day at $232.65. It sits at 99% of its 52-week range ($190.75–$277.60); 14-day RSI is 73, in overbought territory; an average session moves it about 2.1%. For levels, the first level overhead is $300.00 (8.5% away) and the first support below is $275.00 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA trades at $225.00, above its 50-day average of $138.26, and above the 200-day at $72.63. It sits at 100% of its 52-week range ($22.28–$225.00); 14-day RSI is 72, in overbought territory; an average session moves it about 7.1%. For levels, the first level overhead is $250.00 (11.1% away) and the first support below is $200.00 (11.1% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.1% against 2.1% for ABBV, so an identical position size carries roughly 3.4× the daily risk.
The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; MRNA clearing $250.00 or losing $200.00. Until one of them gives way, the relative reading above stands.